Superdisintegrants Market 2027 By Type, Formulation, Therapeutic Area and Geography | The Insight Partners

Superdisintegrants Market to 2027 - Global Analysis and Forecasts by Type (Synthetic Superdisintegrants, Natural Superdisintegrants, Other Superdisintegrants); Formulation (Tablets, Capsules); Therapeutic Area (Neurological Diseases, Gastrointestinal Diseases, Oncology, Inflammatory Diseases, Infectious Diseases, Cardiovascular Diseases, Other Diseases) and Geography

Report Code: TIPRE00004423 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
MARKET INTRODUCTION
The superdisintegrants are the agents that are added in the tablets to improve the breakup of tablet into small fragments in aqueous condition thereby boosting the release of drug into the body. In recent years it has gained the attention from pharmaceutical industry as it increases the solubility of API in body by raising absorption of drug in the body due to which bioavailability of drug also increases. The superdisintegrant agent are used in tablet and capsules.

MARKET DYNAMICS
The superdisintegrants market is anticipated to grow in the forecast period owing to driving factors such as elevated production capacities of pharmaceutical companies which is leading to their consumption, increasing R&D investment on this product range. The market is expecting more growth as the natural substances are also being used as superdisintegrants so these type of findings have given new path for the research.

MARKET SCOPE
The "Global Superdisintegrants Market Analysis to 2027" is a specialized and in-depth study of the pharmaceuticals industry with a special focus on the global market trend analysis. The report aims to provide an overview of enteral feeding formulas market with detailed market segmentation by type, formulation and therapeutic area and geography. The global superdisintegrants market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading enteral feeding formulas market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION
The global superdisintegrant market is segmented on the basis of type, formulation and therapeutic area. Based on type, the market is classified as synthetic superdisintegrants, natural superdisintegrants and other superdisintegrants. On the basis of formulation, the market is classified as tablets and capsules. On the basis of therapeutic area, the market is classified as neurological diseases, gastrointestinal diseases, oncology, inflammatory diseases, infectious diseases, cardiovascular diseases and other diseases.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global superdisintegrants market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The anticoagulants market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting superdisintegrants market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the anticoagulants market in these regions.

MARKET PLAYERS
The reports cover key developments in the superdisintegrants market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from anticoagulants market are anticipated to lucrative growth opportunities in the future with the rising demand for superdisintegrants market in the global market. Below mentioned is the list of few companies engaged in the superdisintegrants market.

The report also includes the profiles of key superdisintegrants market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
  • Ashland Inc.
  • BASF SE
  • DowDuPont
  • JRS Pharma
  • DFE Pharma
  • Rouquette
  • Asahi Kasei corporation
  • Merck KGAA
  • Corel Pharma Chem
  • Avantor performance materials, LLC
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Superdisintegrants Market - By Type
1.3.2 Superdisintegrants Market - By Formulation
1.3.3 Superdisintegrants Market - By Therapeutic Area
1.3.4 Superdisintegrants Market - By Region
1.3.4.1 By Country
2. KEY TAKEWAYS
3. RESEARCH METHODOLOGY
4. SUPERDISINTEGRANTS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. SUPERDISINTEGRANTS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. SUPERDISINTEGRANTS MARKET - GLOBAL MARKET ANALYSIS
6.1. SUPERDISINTEGRANTS - GLOBAL MARKET OVERVIEW
6.2. SUPERDISINTEGRANTS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. SUPERDISINTEGRANTS MARKET - REVENUE AND FORECASTS TO 2027 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. SYNTHETIC SUPERDISINTEGRANTS
7.3.1. Overview
7.3.2. Synthetic Superdisintegrants Market Forecast and Analysis
7.3.3. Crospovidone Market
7.3.3.1. Overview
7.3.3.2. Crospovidone Market Forecast and Analysis
7.3.4. Modified Starch Market
7.3.4.1. Overview
7.3.4.2. Modified Starch Market Forecast and Analysis
7.3.5. Modified Cellulose Market
7.3.5.1. Overview
7.3.5.2. Modified Cellulose Market Forecast and Analysis
7.3.6. Calcium Silicates Market
7.3.6.1. Overview
7.3.6.2. Calcium Silicates Market Forecast and Analysis
7.3.7. Ion Exchange Resins Market
7.3.7.1. Overview
7.3.7.2. Ion Exchange Resins Market Forecast and Analysis
7.4. NATURAL SUPERDISINTEGRANTS
7.4.1. Overview
7.4.2. Natural Superdisintegrants Market Forecast and Analysis
7.5. OTHER SUPERDISINTEGRANTS
7.5.1. Overview
7.5.2. Other Superdisintegrants Market Forecast and Analysis
8. SUPERDISINTEGRANTS MARKET - REVENUE AND FORECASTS TO 2027 - FORMULATION
8.1. OVERVIEW
8.2. FORMULATION MARKET FORECASTS AND ANALYSIS
8.3. TABLETS
8.3.1. Overview
8.3.2. Tablets Market Forecast and Analysis
8.4. CAPSULES
8.4.1. Overview
8.4.2. Capsules Market Forecast and Analysis
9. SUPERDISINTEGRANTS MARKET - REVENUE AND FORECASTS TO 2027 - THERAPEUTIC AREA
9.1. OVERVIEW
9.2. THERAPEUTIC AREA MARKET FORECASTS AND ANALYSIS
9.3. NEUROLOGICAL DISEASES
9.3.1. Overview
9.3.2. Neurological Diseases Market Forecast and Analysis
9.4. GASTROINTESTINAL DISEASES
9.4.1. Overview
9.4.2. Gastrointestinal Diseases Market Forecast and Analysis
9.5. ONCOLOGY
9.5.1. Overview
9.5.2. Oncology Market Forecast and Analysis
9.6. INFLAMMATORY DISEASES
9.6.1. Overview
9.6.2. Inflammatory Diseases Market Forecast and Analysis
9.7. INFECTIOUS DISEASES
9.7.1. Overview
9.7.2. Infectious Diseases Market Forecast and Analysis
9.8. CARDIOVASCULAR DISEASES
9.8.1. Overview
9.8.2. Cardiovascular Diseases Market Forecast and Analysis
9.9. OTHER DISEASES
9.9.1. Overview
9.9.2. Other Diseases Market Forecast and Analysis
10. SUPERDISINTEGRANTS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Superdisintegrants Market Overview
10.1.2 North America Superdisintegrants Market Forecasts and Analysis
10.1.3 North America Superdisintegrants Market Forecasts and Analysis - By Type
10.1.4 North America Superdisintegrants Market Forecasts and Analysis - By Formulation
10.1.5 North America Superdisintegrants Market Forecasts and Analysis - By Therapeutic Area
10.1.6 North America Superdisintegrants Market Forecasts and Analysis - By Countries
10.1.6.1 United States Superdisintegrants Market
10.1.6.1.1 United States Superdisintegrants Market by Type
10.1.6.1.2 United States Superdisintegrants Market by Formulation
10.1.6.1.3 United States Superdisintegrants Market by Therapeutic Area
10.1.6.2 Canada Superdisintegrants Market
10.1.6.2.1 Canada Superdisintegrants Market by Type
10.1.6.2.2 Canada Superdisintegrants Market by Formulation
10.1.6.2.3 Canada Superdisintegrants Market by Therapeutic Area
10.1.6.3 Mexico Superdisintegrants Market
10.1.6.3.1 Mexico Superdisintegrants Market by Type
10.1.6.3.2 Mexico Superdisintegrants Market by Formulation
10.1.6.3.3 Mexico Superdisintegrants Market by Therapeutic Area
10.2. EUROPE
10.2.1 Europe Superdisintegrants Market Overview
10.2.2 Europe Superdisintegrants Market Forecasts and Analysis
10.2.3 Europe Superdisintegrants Market Forecasts and Analysis - By Type
10.2.4 Europe Superdisintegrants Market Forecasts and Analysis - By Formulation
10.2.5 Europe Superdisintegrants Market Forecasts and Analysis - By Therapeutic Area
10.2.6 Europe Superdisintegrants Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Superdisintegrants Market
10.2.6.1.1 Germany Superdisintegrants Market by Type
10.2.6.1.2 Germany Superdisintegrants Market by Formulation
10.2.6.1.3 Germany Superdisintegrants Market by Therapeutic Area
10.2.6.2 France Superdisintegrants Market
10.2.6.2.1 France Superdisintegrants Market by Type
10.2.6.2.2 France Superdisintegrants Market by Formulation
10.2.6.2.3 France Superdisintegrants Market by Therapeutic Area
10.2.6.3 Italy Superdisintegrants Market
10.2.6.3.1 Italy Superdisintegrants Market by Type
10.2.6.3.2 Italy Superdisintegrants Market by Formulation
10.2.6.3.3 Italy Superdisintegrants Market by Therapeutic Area
10.2.6.4 Spain Superdisintegrants Market
10.2.6.4.1 Spain Superdisintegrants Market by Type
10.2.6.4.2 Spain Superdisintegrants Market by Formulation
10.2.6.4.3 Spain Superdisintegrants Market by Therapeutic Area
10.2.6.5 United Kingdom Superdisintegrants Market
10.2.6.5.1 United Kingdom Superdisintegrants Market by Type
10.2.6.5.2 United Kingdom Superdisintegrants Market by Formulation
10.2.6.5.3 United Kingdom Superdisintegrants Market by Therapeutic Area
10.2.6.6 Rest of Europe Superdisintegrants Market
10.2.6.6.1 Rest of Europe Superdisintegrants Market by Type
10.2.6.6.2 Rest of Europe Superdisintegrants Market by Formulation
10.2.6.6.3 Rest of Europe Superdisintegrants Market by Therapeutic Area
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Superdisintegrants Market Overview
10.3.2 Asia-Pacific Superdisintegrants Market Forecasts and Analysis
10.3.3 Asia-Pacific Superdisintegrants Market Forecasts and Analysis - By Type
10.3.4 Asia-Pacific Superdisintegrants Market Forecasts and Analysis - By Formulation
10.3.5 Asia-Pacific Superdisintegrants Market Forecasts and Analysis - By Therapeutic Area
10.3.6 Asia-Pacific Superdisintegrants Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Superdisintegrants Market
10.3.6.1.1 Australia Superdisintegrants Market by Type
10.3.6.1.2 Australia Superdisintegrants Market by Formulation
10.3.6.1.3 Australia Superdisintegrants Market by Therapeutic Area
10.3.6.2 China Superdisintegrants Market
10.3.6.2.1 China Superdisintegrants Market by Type
10.3.6.2.2 China Superdisintegrants Market by Formulation
10.3.6.2.3 China Superdisintegrants Market by Therapeutic Area
10.3.6.3 India Superdisintegrants Market
10.3.6.3.1 India Superdisintegrants Market by Type
10.3.6.3.2 India Superdisintegrants Market by Formulation
10.3.6.3.3 India Superdisintegrants Market by Therapeutic Area
10.3.6.4 Japan Superdisintegrants Market
10.3.6.4.1 Japan Superdisintegrants Market by Type
10.3.6.4.2 Japan Superdisintegrants Market by Formulation
10.3.6.4.3 Japan Superdisintegrants Market by Therapeutic Area
10.3.6.5 South Korea Superdisintegrants Market
10.3.6.5.1 South Korea Superdisintegrants Market by Type
10.3.6.5.2 South Korea Superdisintegrants Market by Formulation
10.3.6.5.3 South Korea Superdisintegrants Market by Therapeutic Area
10.3.6.6 Rest of Asia-Pacific Superdisintegrants Market
10.3.6.6.1 Rest of Asia-Pacific Superdisintegrants Market by Type
10.3.6.6.2 Rest of Asia-Pacific Superdisintegrants Market by Formulation
10.3.6.6.3 Rest of Asia-Pacific Superdisintegrants Market by Therapeutic Area
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Superdisintegrants Market Overview
10.4.2 Middle East and Africa Superdisintegrants Market Forecasts and Analysis
10.4.3 Middle East and Africa Superdisintegrants Market Forecasts and Analysis - By Type
10.4.4 Middle East and Africa Superdisintegrants Market Forecasts and Analysis - By Formulation
10.4.5 Middle East and Africa Superdisintegrants Market Forecasts and Analysis - By Therapeutic Area
10.4.6 Middle East and Africa Superdisintegrants Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Superdisintegrants Market
10.4.6.1.1 South Africa Superdisintegrants Market by Type
10.4.6.1.2 South Africa Superdisintegrants Market by Formulation
10.4.6.1.3 South Africa Superdisintegrants Market by Therapeutic Area
10.4.6.2 Saudi Arabia Superdisintegrants Market
10.4.6.2.1 Saudi Arabia Superdisintegrants Market by Type
10.4.6.2.2 Saudi Arabia Superdisintegrants Market by Formulation
10.4.6.2.3 Saudi Arabia Superdisintegrants Market by Therapeutic Area
10.4.6.3 U.A.E Superdisintegrants Market
10.4.6.3.1 U.A.E Superdisintegrants Market by Type
10.4.6.3.2 U.A.E Superdisintegrants Market by Formulation
10.4.6.3.3 U.A.E Superdisintegrants Market by Therapeutic Area
10.4.6.4 Rest of Middle East and Africa Superdisintegrants Market
10.4.6.4.1 Rest of Middle East and Africa Superdisintegrants Market by Type
10.4.6.4.2 Rest of Middle East and Africa Superdisintegrants Market by Formulation
10.4.6.4.3 Rest of Middle East and Africa Superdisintegrants Market by Therapeutic Area
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Superdisintegrants Market Overview
10.5.2 South and Central America Superdisintegrants Market Forecasts and Analysis
10.5.3 South and Central America Superdisintegrants Market Forecasts and Analysis - By Type
10.5.4 South and Central America Superdisintegrants Market Forecasts and Analysis - By Formulation
10.5.5 South and Central America Superdisintegrants Market Forecasts and Analysis - By Therapeutic Area
10.5.6 South and Central America Superdisintegrants Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Superdisintegrants Market
10.5.6.1.1 Brazil Superdisintegrants Market by Type
10.5.6.1.2 Brazil Superdisintegrants Market by Formulation
10.5.6.1.3 Brazil Superdisintegrants Market by Therapeutic Area
10.5.6.2 Argentina Superdisintegrants Market
10.5.6.2.1 Argentina Superdisintegrants Market by Type
10.5.6.2.2 Argentina Superdisintegrants Market by Formulation
10.5.6.2.3 Argentina Superdisintegrants Market by Therapeutic Area
10.5.6.3 Rest of South and Central America Superdisintegrants Market
10.5.6.3.1 Rest of South and Central America Superdisintegrants Market by Type
10.5.6.3.2 Rest of South and Central America Superdisintegrants Market by Formulation
10.5.6.3.3 Rest of South and Central America Superdisintegrants Market by Therapeutic Area
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. SUPERDISINTEGRANTS MARKET, KEY COMPANY PROFILES
12.1. ASHLAND INC.
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. BASF SE
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. DUPONT
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. JRS PHARMA
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. DFE PHARMA
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. ROQUETTE
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. ASAHI KASEI CORPORATION
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. MERCK KGAA
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. COREL PHARMA CHEM
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. AVANTOR PERFORMANCE MATERIALS, LLC
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. ASHLAND INC
2. BASF SE
3. DUPONT
4. JRS PHARMA
5. DFE PHARMA
6. ROQUETTE
7. ASAHI KASEI CORPORATION
8. MERCK KGAA
9. COREL PHARMA CHEM
10. AVANTOR PERFORMANCE MATERIALS, LLC